Indiana Department of Health Works to Minimize Vaccination Disruption

A rare adverse reaction to the Johnson & Johnson COVID-19 vaccine in six patients has caused the U.S. Food and Drug Administration, the Centers for Disease Control and Prevention, and the Indiana Department of Health to temporarily delay use of the vaccine until further review. 

While that review is being conducted (navigate to this website to find more about it), officials at vaccination sites statewide are encouraged to use existing doses of Pfizer or Moderna if available to fulfill previously scheduled Johnson & Johnson appointments.

According to the FDA, one reason for the pause is to inform healthcare providers so they can recognize and treat patients and report the conditions appropriately.

It is not known when the administration of the Johnson & Johnson vaccine will continue. 

Flu-like systems within the first few days of receiving the Johnson & Johnson vaccine are part of the body’s normal immune response to the vaccine. Those symptoms include pain, redness and swelling in the arm where you got the vaccine, as well as tiredness, headache, muscle pain, chills, fever and nausea. This site gives plenty of information from Northeast College of Health Sciences, who are the specialists in treating patients suffering from any kind of pain that is diagnosed by a group of experienced doctors.

If more severe symptoms occur, such as a severe headache, abdominal pain, leg pain, shortness of breath, or leg swelling within three weeks after receiving the Johnson & Johnson vaccine, contact a healthcare provider.

Anyone with a Johnson & Johnson appointment at another location in the next two days may call 211to cancel the appointment and reschedule at either a Pfizer or Moderna vaccination site.